EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Angiographic Quantitative Flow Ratio–Guided Treatment of Patients With Physiologically Intermediate Coronary Lesions

Jiannan Dai, Changdong Guan, Xueming Xu, Jingbo Hou, Haibo Jia iD, Huai Yu, Zening Jin, Guosheng Fu iD, Xiaofan Wu iD, Liansheng Wang iD, Rongchong Huang iD, Zhujun Shen iD und 9 weitere

Journal of the American Heart Association · 2025-04 · 14 (7)

DOI: 10.1161/jaha.124.035756 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2025-04. Verfasst von Jiannan Dai und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The Second Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province China. Hauptthemen laut MEDLINE: Coronary Angiography, Percutaneous Coronary Intervention, Coronary Artery Disease, Fractional Flow Reserve, Myocardial. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The FAVOR III (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients With Coronary Artery Disease) China trial reported improved clinical outcomes with percutaneous coronary intervention guided by quantitative flow ratio (QFR) compared with angiography. Whether these benefits also apply for patients presenting with “uncertainty‐zone” lesions of intermediate physiological significance is uncertain. This study aims to examine the impact of QFR guidance versus angiography guidance on the management and outcomes of percutaneous coronary intervention in uncertainty‐zone lesions. Methods and Results In this prespecified subgroup analysis, offline QFR assessment categorized 873 patients (22.9%) into the uncertainty‐zone subgroup, defined as having an offline QFR of 0.75 to 0.85 in all coronary arteries with a lesion causing ≥50% diameter stenosis. At 2 years, the rate of major adverse cardiac events, a composite of all‐cause death, myocardial infarction, or ischemia‐driven revascularization, occurred in 31 patients (7.0%) in the QFR‐guided group and 35 patients (8.3%) in the angiography‐guided group (hazard ratio [HR], 0.85 [95% CI, 0.52–1.37]). In landmark analysis, the relative treatment effect of QFR guidance versus angiography guidance on major adverse cardiac events differed before 1 year (4.7% versus 3.8%; HR, 1.25 [95% CI, 0.65–2.40]) and after 1 year (2.3% versus 5.5%; HR, 0.41 [95% CI, 0.20–0.87]) ( P interaction =0.03), driven by fewer nonprocedural myocardial infarctions and ischemia‐driven revascularizations in the QFR‐guided group after 1‐year follow‐up.

Conclusions

In the modest‐sized subgroup of patients with physiologically intermediate lesions randomized in the FAVOR III China trial, 2‐year clinical outcomes were not significantly improved with a QFR‐guided revascularization strategy compared with angiography guidance. Registration URL: https://www.clinicaltrials.gov ; Identifier: NCT 03656848.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary AngiographyPercutaneous Coronary InterventionCoronary Artery DiseaseFractional Flow Reserve, MyocardialCoronary VesselsCoronary StenosisHumansFemaleMaleMiddle AgedAgedTreatment OutcomeChina

Stichwörter der Autor:innen

major adverse cardiac eventspercutaneous coronary interventionquantitative flow ratio“uncertainty‐zone” lesions

Autor:innen und Institutionen

  • Department of Cardiology The Second Affiliated Hospital of Harbin Medical University Harbin Heilongjiang Province China.
  • The Key Laboratory of Myocardial Ischemia Chinese Ministry of Education Harbin Heilongjiang Province China.
  • Department of Cardiology National Clinical Research Center for Cardiovascular Diseases Fuwai Hospital National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College Beij…
  • Department of Cardiology Beijing Tiantan Hospital Capital Medical University Beijing China.
  • Department of Cardiology Sir Run Run Shaw Hospital Zhejiang University School of Medicine Hangzhou Zhejiang Province China.
  • Department of Cardiology Beijing Anzhen Hospital Capital Medical University Beijing China.

ORCID-Profile: Haibo Jia, Guosheng Fu, Xiaofan Wu, Liansheng Wang, Rongchong Huang, Zhujun Shen, Yuanzhe Jin, Lei Song, Shubin Qiao, Bo Yu, Bo Xu, Gregg W Stone

Zitieren

APA

Dai, J., Guan, C., Xu, X., Hou, J., Jia, H., Yu, H., Jin, Z., Fu, G., Wu, X., Wang, L., Huang, R., Shen, Z., Zhao, Y., Jin, Y., Song, L., Tu, S., Qiao, S., Yu, B., Xu, B., …, & FAVOR III China study group (2025). Angiographic Quantitative Flow Ratio–Guided Treatment of Patients With Physiologically Intermediate Coronary Lesions. Journal of the American Heart Association, 14(7). https://doi.org/10.1161/jaha.124.035756

Vancouver

Dai J, Guan C, Xu X, Hou J, Jia H, Yu H, et al. Angiographic Quantitative Flow Ratio–Guided Treatment of Patients With Physiologically Intermediate Coronary Lesions. Journal of the American Heart Association. 2025;14(7). doi:10.1161/jaha.124.035756

BibTeX
@article{Dai2025,
  author = {Dai, Jiannan and Guan, Changdong and Xu, Xueming and Hou, Jingbo and Jia, Haibo and Yu, Huai and Jin, Zening and Fu, Guosheng and Wu, Xiaofan and Wang, Liansheng and Huang, Rongchong and Shen, Zhujun and Zhao, Yanyan and Jin, Yuanzhe and Song, Lei and Tu, Shengxian and Qiao, Shubin and Yu, Bo and Xu, Bo and Stone, Gregg W and FAVOR III China study group, FAVOR III China study group},
  title = {Angiographic Quantitative Flow Ratio–Guided Treatment of Patients With Physiologically Intermediate Coronary Lesions},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {7},
  doi = {10.1161/jaha.124.035756}
}
Kostenlos starten →